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F e at u r e A r t i c l e

 enetic Dominance & Cellular
G
Processes

R o b e rt D. S e ag e r

Abstract
In learning genetics, many students misunderstand and misinterpret what
“dominance” means. Understanding is easier if students realize that dominance
is not a mechanism, but rather a consequence of underlying cellular processes.
For example, metabolic pathways are often little affected by changes in enzyme
concentration. This means that enzyme-producing alleles usually show complete dominance. For genes producing nonenzymatic proteins such as collagen
or hemoglobin, the amount of product matters, and dominance relationships
are more complicated. Furthermore, with hemoglobin, dominance can change
depending on what aspect of the phenotype is being studied and on the environmental conditions. X-linked genes are a special case, whether enzymatic or not.
Because of X-chromosome inactivation, only one X-linked allele can be active in
a cell, which means that the concept of dominance cannot be applied at the cellular level. Instead, a type of dominance is demonstrated at the individual level;
but even so, dominant traits may fail to be expressed, and recessive traits can be
expressed. Teaching not only what is happening but why it’s happening will give
students a deeper understanding, not only of dominance relationships, but of the
underlying cellular processes as well.
Key Words: Dominance relationships; enzymes and structural proteins;
X-chromosome genes and dominance; instruction.

students understand cellular processes, and understanding cellular
processes helps students understand dominance relationships.
Dominance pertains only to the phenotype (observable char
acteristics) of a heterozygote (Table 1). It describes the relationship
between allelic products, between products of different versions of
the same gene in a heterozygous individual. Alleles by themselves
do not have dominance; dominance/recessiveness is not built into
our DNA. Referring to an allele by itself as dominant or recessive is
misleading and can hamper understanding. In addition, dominance
relationships apply only to a single gene; one gene cannot be domi
nant to a different gene, even though it may alter or even suppress
the function of that gene.
I will discuss three types of dominance relationships here:
(1) complete dominance (or being haplo-sufficient); (2) incomplete
dominance (or being haplo-insufficient); and (3) the interesting and
unusual case of X-chromosome genes. Table 2 explains the mecha
nisms underlying complete and incomplete dominance. Although
the following examples are restricted to humans, the same principles
apply to all diploids, with the exception of X-linked genes in organ
isms such as Drosophila, in which X-chromosome inactivation does
not occur.

Dominance relationships are “commonly misunderstood and mis
interpreted” by students learning genetics. Some believe that “dom JJ
Genes That Code for an Enzyme:
inance … depends on some mysterious, unknown and perhaps
unknowable force” (Heim, 1991, p. 94). Others say that it is “based Complete Dominance
on power, strength and value,” which leads to the misconceptions that We often study traits in which different genotypes produce obvious
dominant alleles dominate recessive alleles or that dominant alleles will and noticeably different phenotypes, as with albinism, Tay Sachs
naturally become more frequent in a popula
disease, phenylketonuria, and many others.
tion (Allchin, 2000, p. 633; for other examples
For these, there is complete dominance because
Dominance relationships
of student misunderstandings of dominance,
a single functional allele is sufficient to pro
see Redfield, 2012; Smith, 2014a, b).
duce the nondisease phenotype (Table 2). This
are “commonly
On the contrary, dominance is not a force or
relationship is common in genes that code
a power. Dominance is not a mechanism; rather,
for enzymes, as in the three examples above
misunderstood and
dominance relationships are a result. They are
(Lanza & Cress, 2001).
misinterpreted” by
consequences of how gene products function
Students could be asked what this tells
in a cell. Understanding goes both ways –
us about enzymes. First, it emphasizes that
students learning genetics.
understanding dominance relationships helps
enzymes, by their nature, are not used up
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Table 1. Genes and alleles. The terms gene and allele are often used
incorrectly. For example, there is no cystic fibrosis gene; instead,
there is a gene that codes for a protein that regulates sodium and
chloride transport across epithelial cell membranes. An individual
with two altered or nonfunctional versions (alleles) of this gene has
cystic fibrosis.

Collagen is also the largest, most complex
macromolecule found in humans. The Type
I collagen genes are correspondingly large,
and they frequently mutate as a consequence,
leading to >300 known connective-tissue
disorders in humans (Di Lullo et al., 2002).
A single Type I collagen disorder, osteogen
Gene
The unit of heredity; all genes discussed here code
esis imperfecta (see below), is associated
for a polypeptide/protein.
with >800 independent mutations (Marini
et al., 2007). What is the effect of these
Alleles
Different versions of the same gene; genes have
mutations?
many alleles.
Type I collagen is a structural protein
Homozygote/homozygous
The two alleles are the same (homo).
that helps support the body, just as beams
Heterozygote/heterozygous The two alleles are different (hetero).
and columns provide structural support for
a building. (Enzymes, by contrast, are analo
gous to building tools, like hammers and saws,
which are reused many times.) What would
Table 2. Gene action and dominance. “A1” and “A2” are used for the
happen if there were no structural support at
alleles because using “A” and “a” is appropriate only when there is
all? There would be no building, and no body.
complete dominance.
Homozygotes that lack any functional Type I
collagen do not survive. Heterozygotes pro
Alleles
A1
Produces a functional product/protein
duce about half of the structurally sound col
A2
Produces a nonfunctional product or no
umns and beams the building (body) needs
product at all
(see Table 2); the other half is either missing
Genotypes A1 A1 homozygote Produces functional product
or defective (the mutated Type I collagen
allele either makes no product at all or makes
A1 A2 heterozygote Produces about half as much functional
a defective one). Students should expect dire
product as A1 A1
consequences in this case.
A2 A2 homozygote No functional product (or no product at all)
What does this predict about dominance
produced
relationships, about the phenotype of the
Notes: Dominance pertains to the phenotype of the heterozygote. Complete (or full) dominance
heterozygote? The amount of functional pro
describes the situation when the heterozygote and the A1 A1 homozygote have the same phenotype.
tein matters; a Type I collagen heterozygote
This happens if “about half as much functional product” is enough for full functioning. Since only one
should be affected. The fragile-bone disorder
functional allele (A1) is sufficient for full functioning, this can also be called haplo-sufficient (= “one
osteogenesis imperfecta Type I is an example
allele is sufficient”). If “about half as much functional product” is not enough for full functioning, the
of this; the body is unsound and may even
heterozygote will have a different phenotype than either homozygote. This is incomplete dominance;
the functional allele (A1) is haplo-insufficient.
collapse – some Type I collagen mutations
are lethal (Marini et al., 2007). For further
information on Type I collagen and human
during a reaction. From this, it follows that in many cases, not genetics in general, see Online Mendelian Inheritance in Man
a lot of enzyme is necessary for proper functioning, given that (http://www.omim.org).
decreasing the amount of available enzyme by half has no effect.
An overall conclusion is that enzymatic (metabolic) pathways in Hemoglobins: An Overview
general are not particularly sensitive to changes in enzyme con Hemoglobin consists of two different proteins and is thus the product
centration. But what about proteins that are not enzymes and that of two different genes; in adults, these are the hemoglobin α and
are needed in large quantities, such as collagen and hemoglobin hemoglobin β genes. Adult hemoglobin (α2β2) consists of two copies
(Wilkie, 1994)?
of each protein. Three other functional hemoglobin genes in humans,
γ, δ and ε, are variants of the β gene – α2ε2 appears in the embryo,
α2γ2 in the fetus, and α2δ2 comprises a small portion of adult hemo
JJ Genes That Do Not Code for an Enzyme:
globin (Barton et al., 2007, and accompanying website).
A good question for students is “Why are there so many hemo
When the Amount Matters
globins?” More precisely, “What are the differences among the dif
Type I Collagen
ferent hemoglobins, and are these differences appropriate for their
There are many collagen genes and many different collagen proteins. different developmental environments?” For example, α2γ2 (fetal
Collagens hold our bodies together (“collagen” means “glue pro hemoglobin) has a slightly higher affinity for oxygen than the adult
ducing”); for example, collagens are essential components of bones hemoglobin (α2β2) that later replaces it. How is this difference tied to
and tendons. A critical collagen is Type I, the major component of the different oxygen needs of the fetus versus the adult?
connective tissue and the most abundant protein found in humans
Fetal hemoglobin’s higher affinity for oxygen helps the fetus
(Prockop & Kivirikko, 1995).
by making oxygen transport across the placenta more efficient
The american biology teacher	Genetic Dominance
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water, A type hemoglobin is water soluble or hydrophilic (“water
loving”).
By contrast, valine, its replacement in S hemoglobin, ends with
non-water-soluble methyl groups (–CH3). Thus, S hemoglobin is less
water-soluble or hydrophobic (“water hating”) and, therefore, harder
to move around within the cell than A hemoglobin (Mosby, 2009).
This amino acid difference is not much of a problem when
S hemoglobin is carrying oxygen. However, when the oxygen is
released, both S and A hemoglobin molecules change shape, exposing
a formerly hidden and hydrophobic part of the molecule.
This is not a problem with the hydrophilic A hemoglobin, but
it is with S hemoglobin. The hydrophobic valine of S hemoglobin is
attracted to the newly exposed hydrophobic part of adjacent hemo
globins. This continues until insoluble, and unusable, clumps of
hemoglobin are formed within the red blood cells (RBCs). An excel
lent illustration of this is on a website maintained by the University
of Wisconsin (2012).
The consequence for SS homozygous individuals is sickle cell
anemia, in which the oxygen-carrying capacity of RBCs is greatly
reduced. Making things worse, S hemoglobin releases its oxygen
more easily, and thus changes shape more easily, than A hemo
globin (Riggs & Wells, 1961). Therefore, in SS people, the clumping
β hemoglobin & sickle cell anemia
The β hemoglobin variant associated with sickle cell anemia (Medzhitov problem will happen fairly quickly. The RBCs become distorted and
et al., 2012) is well known and displays complex dominance relatively inflexible, and some become sickle shaped. Students can
relationships. The sickle cell allele codes for an altered, less func be directed to an excellent website created by Harvard University
tional β hemoglobin (“S”), and as with Type I collagen, the amount of (2002), which helps explain this situation.
The consequences are more complicated for heterozygous
fully functional β hemoglobin (“A”) matters (Table 3).
Homozygosity for the altered β hemoglobin (SS; sickle cell individuals (AS – sickle cell trait). Questions of dominance pertain
anemia) causes severe health risks and is often lethal: in sub- to the phenotype of the heterozygote (see Table 2). It is critical to
Saharan Africa, an estimated 50–80% of individuals with sickle remember, when studying dominance relationships, that phenotypes
cell anemia die before adulthood. The World Health Organization result from a combination of genetic and environmental influences.
estimates that 70% of these deaths could be avoided by the use of AS heterozygotes provide a good example of this. When oxygen levels
simple, cost-effective intervention strategies available in countries are sufficient, a single functional allele (A) is enough to supply the
such as the United States, where up to 94% of individuals with body with adequate oxygen; A is dominant to S.
This situation reverses for AS heterozygotes when there is less
sickle cell anemia survive to at least 18 years of age (Makani et al.,
oxygen in the air because of high altitude, a higher metabolic need
2011).
Students can be challenged to explain why S hemoglobin is such for oxygen because of physical exertion, or both. In these cases,
a problem. A good way to start is to compare the chemical composi there is not enough fully functional A hemoglobin to supply the body
tion of A versus S hemoglobin. As is well documented, there is only with adequate oxygen, and S becomes dominant to A. The prob
a single amino acid difference: Glutamic acid in the fully functional lems associated with the S allele occur as they do in SS homozygotes;
A molecule has been replaced by valine in the S variant. Why is this hemoglobin is less likely to be fully oxygenated, hemoglobin aggre
gates are more likely to form, and many of the red blood cells sickle.
change so significant?
First, the relevant amino acid is exposed on the surface of the A heterozygous individual experiences symptoms similar to sickle
hemoglobin molecule. This means that it can interact both with the cell anemia (see Table 3).
This environmentally altered phenotype is a serious public health
aqueous cellular environment and with other hemoglobin molecules.
Second, the glutamic acid side group in the nonmutated A hemo issue. Sickle cell trait (AS) is often undiagnosed unless a problem
globin ends in carboxylic acid (–COOH). Since acids are soluble in occurs, and this has led to military recruits dying during basic training
(Eckart et al., 2004) and athletes dying during
intense workouts (Eichner, 2007). Recently
the National Athletic Trainers’ Association
Table 3. “A” is fully functional β hemoglobin. This can be confusing;
issued a position statement on preventing
“A” has nothing to do with α hemoglobin. “S” is sickle cell β hemosudden death in sports, including appro
globin.
priate standards for working with athletes
Genotype Phenotype
with sickle cell trait (Casa et al., 2012).
AA
No problems with hemoglobin (no sickle cell problems)
The harmful effects of high altitude and
physical
exertion were experienced by Ryan
AS
Sickle cell trait: sickle cell problems under oxygen stress, otherwise OK
Clark, a defensive back with the Pittsburgh
SS
Sickle cell anemia: severe sickle cell problems in all environments
Steelers football team. Clark has the sickle
(Elmissbah & Abdalla, 2012). Outside of the uterus, this can cause
problems. If the amount of oxygen in the body is low (hypoxia),
fetal hemoglobin is harmful. Because it holds onto its oxygen more
strongly than adult hemoglobin, fetal hemoglobin would release less
oxygen to the body to counter the hypoxia.
A further, seemingly simple question: Can any vertebrate survive
without hemoglobin? All vertebrates require oxygen, and all verte
brates started out with hemoglobin. Are there conditions in which
hemoglobin actually became harmful and was selected against?
Surprisingly, yes: There is a group of fish living in very cold
Antarctic waters. Under these conditions, hemoglobin would
make the blood too viscous (too thick) and thus extremely hard to
circulate. A good analogy is how slowly syrup kept in the refrig
erator (the “Antarctic”) pours, compared with syrup kept at room
temperature. Indeed, it was selection against hemoglobin and for
reduced blood viscosity that allowed these fish to expand into and
inhabit Antarctic waters in the first place (di Prisco et al., 2007 [more
technical]; Carroll, 2009 [less technical]). In every other case, as with
Type I collagen, survival is impossible without hemoglobin; having
no hemoglobin at all is lethal.
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cell trait (AS), and in 2007, he played foot
ball at the high-altitude Mile High Stadium
in Denver, Colorado. The consequences were
devastating. Clark almost died and had to
have his spleen and gallbladder removed
(Quick, 2012).

Hemoglobin, sickle cell, & malaria

Table 4. The effect of malaria on people with different β hemoglobin
genotypes (this is an extension of Table 3).
Genotype

Phenotype

AA

No problems with hemoglobin (no sickle cell problems), no
increased resistance to malaria

AS

Sickle cell trait: sickle cell problems when oxygen levels are low,
otherwise OK; increased resistance to malaria

There is a further complication. The reason
SS
Sickle cell anemia: severe sickle cells problems in all environments;
for the relatively high frequency of S, the
probably some resistance to malarial infections but not to malaria
sickle allele, is that AS heterozygotes have an
itself
increased resistance to malaria. In malarial
environments (which typically occur at low
altitudes), S is dominant to A for malarial resistance (the AS heterozy therefore, traditional dominance relationships for X-linked genes do
gote is more malarial resistant than the AA homozygote). By contrast, not exist either.
Even though no single cell is functionally heterozygous, an XX
S is recessive to A for sickle cell anemia unless there is significant
female can be heterozygous as a whole, but with a crucial difference.
physical exertion (given that the altitudes are low; Table 4).
What about SS homozygotes? If one S allele offers protection In an autosomal (non-sex-chromosome) heterozygote, if one allele is
against malaria, wouldn’t two of them be even better? The answer defective, every cell will produce functional product. In an X-linked
is paradoxical: A 5-year study in Tanzania found that individuals heterozygote, if one allele is defective and the other functional, the
with sickle cell anemia (SCA) indeed had lower levels of the malarial consequence of X-chromosome inactivation is that some cells will
parasite than individuals without SCA, but SCA individuals were at produce only the functional product, whereas other cells will produce
a higher risk for severe anemia and death than those without SCA only a defective product or no product at all.
There is another important consideration. Human X-chromosome
(Makani et al., 2010).
The best explanation of this paradox is that individuals with SCA inactivation occurs very early in development, when the embryo has
do have some protection from malarial infection (lower parasitemia). few cells (Lyon, 2002). In a heterozygote, which X chromosome/
However, because of their generally weakened condition, they have a allele is inactivated in any given cell is random, but random does
much lower tolerance for malaria itself. In addition, malaria itself can not necessarily mean equal, especially when the sample size is small.
Students can visualize this with sets of 20 coins, corresponding to
cause anemia, greatly worsening the anemia already present.
To summarize, the β hemoglobin sickle allele (S), when homozy X-chromosome inactivation at the 20-cell stage. Each coin represents
gous, is both harmful and, in malarial regions, somewhat helpful, a cell, and the two sides of the coin represent the different alleles –
because it apparently confers some resistance to malaria. However, the coin is “heterozygous.” When flipped, only one allele (one side)
the benefits of this resistance are overshadowed by the greater is seen; the face-down side represents the inactivated allele in the
vulnerability of SS homozygotes to the effects of malaria. When Barr body.
Students could be asked how often they expect an equal number
paired with a functional β hemoglobin allele (AS), S is beneficial in
malarial regions, neutral if malaria is absent, and harmful if the indi of heads and tails – this can help them understand probability. The
different sets of coins will display different patterns, and – perhaps
vidual is undergoing oxygen stress.
surprisingly – seldom will there be an equal number of heads and
tails. The coins will be binomially distributed; using this distribution,
JJ X-linked Genes: A Special Case
it can be calculated that only 18% of the time will there be an equal
In mammals, both males and females have only one active (functional) division of coins/cells.
The consequences of this can be observed in Lesch-Nyhan
X chromosome per cell. Although this occurs no matter how many
X chromosomes are present (e.g., in XXX or XXY individuals), the syndrome. Lesch-Nyhan is the result of a defective allele of an
following discussion is restricted to XX females and XY males. If an X-linked enzyme-producing gene involved in purine metabolism.
XX female is genetically heterozygous, in each of her cells only one of Because males have only one X chromosome, affected males will show
her two X-linked alleles is expressed. The other X chromosome coils symptoms, the severity of which depends on the specific nature of
the mutation. More than 300 different disease-associated mutations
up and becomes inactive (i.e. becomes a Barr body).
This happens independently in each initial cell, which means have been identified (Torres et al., 2013). The least affected individ
that some cells will have one of the alleles inactivated and other uals build up uric acid, and the associated gout can be successfully
cells will have the other allele inactivated. Heterozygous females treated. Lesch-Nyhan syndrome is the most severe manifestation –
thus have two different cell populations. This initial inactivation which, in addition to the buildup of uric acid, involves poor muscle
happens only once, and which allele is inactive is stably inher control, mental impairment, and self-mutilation. While the uric acid
ited. All future cells will have the same active (expressed) and problem is amenable to treatment, the cause of the neurological
inactive (not expressed) X chromosome (and X-linked allele) as the problems is poorly understood, and effective treatments do not exist
(Torres et al., 2012).
initial cell.
As far as females are concerned, recall that a single functional
Remember that dominance relationships are a function of the
phenotype of a heterozygote (see Table 2). X-linked heterozygotes do allele of an enzyme-producing gene is most often completely domi
not exist at the cellular level because both alleles are not expressed; nant over a nonfunctional allele (see Table 1). Because males with a
The american biology teacher	Genetic Dominance
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single functional allele do not show symptoms, it might be expected
that the same is true for females – while homozygous females should
be affected, heterozygous females with their single functional allele
should not be.
But they often are. Because the gene is X-linked, some cells will
produce functional enzyme and others will not. Remind students of
the skewed ratios frequently produced when 20 coins are flipped;
if the ratio is skewed toward cells that do not produce functional
enzyme, heterozygous females can be affected.
A particularly instructive case involves identical twin (monozy
gotic) females, one of whom is clinically normal while the other has
Lesch-Nyhan. The twins are identical in their DNA and identical
in their genotypes – both are heterozygous for the same mutation
(De Gregorio et al., 2005), so something else must be happening.
Students with a good understanding of the material should be
able to explain this finding. X-chromosome inactivation, even in
genetically identical twins, is different in each of them because it is
random. The affected twin had a skewed pattern of inactivation in
which the chromosome carrying the functional allele was preferen
tially inactivated; the unaffected twin had the opposite.
What about a nonenzymatic X-linked structural protein such as
dystrophin, the lack of which causes muscular dystrophy? Dystrophin
is part of the cell membranes of striated muscle fibers (Campbell &
Kahl, 1989). It helps link muscle cells to the extracellular matrix,
thereby helping maintain muscle integrity (Ibraghimov-Beskrovnaya
et al., 1992). Unlike Type I collagen, in which the amount of product
matters, a single functional allele produces enough dystrophin for full
functioning, as shown by males who have a single functional allele
but not muscular dystrophy.
Heterozygous females with some degree of muscular dystrophy
are relatively common. Dubowitz in 1960 described ~40 such
heterozygous females (by contrast, only a few heterozygous females
have been identified with Lesch-Nyhan syndrome). As with LeschNyhan, in a pair of identical (monozygotic) twin girls, one twin had
muscular dystrophy whereas the other did not (Richards et al., 1990).
Many, but not all, of the muscle fibers in the twin with muscular dys
trophy lacked dystrophin.
This illustrates another complication when considering females
heterozygous for X-linked genes. During differentiation, different cell
lineages lead to different structures. When X-chromosome inactiva
tion occurs, not only can the overall ratio be skewed between cells
expressing and cells not expressing the functional allele, but there can
be different ratios in different parts of the body. For example, if most of
the cells destined to become muscle fibers have a highly skewed ratio,
with an even greater frequency of cells unable to make dystrophin, the
muscular dystrophy symptoms will be even more severe.
This can also be illustrated with sets of 20 coins. Recall that the
two sides of the coin represent the two different alleles, and when
the coin is flipped, only one allele (one side) is seen; the face-down
side represents the Barr body. Now (without looking) separate out
five or six of these as muscle progenitor cells and look at the ratio;
it may be the same as the overall ratio, but it also might be skewed
toward more or fewer functional alleles.
JJ

Conclusions

Biology (and science in general) can be mysterious (and boring) if
students do not adequately understand the mechanisms underlying
580
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what they are studying. As teachers, we need to go beyond what is
happening and teach why it’s happening. Unfortunately, biology can
be taught as a “what subject” – as a memorization of facts without
appropriate context.
It is important to remember that concepts come first and terms
later; terms enable us to talk about concepts, but they are secondary to
understanding the concepts themselves. For example, a student who
can diagram cell division but cannot name the different stages knows
most of what is necessary for a good understanding of cell division.
A student who has memorized the names of the stages but cannot
draw cell division knows nothing of worth about the process.
Such is the case with dominance relationships – they can seem
like magic (Heim, 1991). Understanding the why of dominance
requires understanding the underlying genetic/cellular processes,
such as the distinction between enzymes and structural proteins and
the effects of X-chromosome inactivation. Students will then under
stand that dominance relationships are the consequence of cellular
processes and, as such, are themselves understandable.
JJ
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